Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (7)

2008

  1. Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates

    NeuroImage, Vol. 42, Núm. 1, pp. 248-251

2007

  1. In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias

    Neurobiology of Disease, Vol. 27, Núm. 2, pp. 220-227

2005

  1. Insights into Parkinson's disease models and neurotoxicity using non-invasive imaging

    Toxicology and Applied Pharmacology

2004

  1. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging

    Journal of Neuroscience, Vol. 24, Núm. 43, pp. 9553-9560

  2. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease

    Journal of Neuroinflammation, Vol. 1

2003

  1. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model

    NeuroImage, Vol. 20, Núm. 2, pp. 1064-1075

2002

  1. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Núm. 4, pp. 2344-2349